Validation of NeoPrediX B.1 algorithm performance in predicting individual bilirubin progression - a prospective multi-center study
Monday, May 1, 2023
9:15 AM – 9:30 AM ET
Location: Convention Center: 150 B
Publication Number: 3125.6
Gilbert Koch, University Children's Hospital Basel, Switzerland, Basel, Basel-Stadt, Switzerland; Britta Steffens, University Children's Hospital (UKBB) Basel, Basel, Basel-Stadt, Switzerland; Axel Franz, Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg, Germany; Marc Pfister, Children's University Hospital Basel (UKBB), Basel, Basel-Stadt, Switzerland; Sven Wellmann, University of Regensburg, Regensburg, Bayern, Germany
Presenting Author(s)
Gilbert Koch, PhD (he/him/his)
Senior Research Fellow University Children's Hospital Basel, Switzerland Basel, Basel-Stadt, Switzerland
Disclosure(s):
Britta Steffens, PhD: NeoPrediX AG (Ongoing) (Products/Services: Employment with an ineligible company)
Gilbert Koch, n/a: NeoPrediX AG (Ongoing) (Products/Services: Employment with an ineligible company)
Axel Franz, MD: Hipp (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Löwenstein Medical (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Neo-PrediX (Ongoing) (Products/Services: Contractor including contracted research); Stephan (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Marc Pfister, MD: NeoPrediX (Ongoing) (Products/Services: Employment with an ineligible company)
Sven Wellmann, MD: Neopredix (Ongoing) (Products/Services: Board Member or Executive Role, Intellectual Property including patent beneficiary and royalties)
